RxDoctor Payments Data

Espiridion Elio, MD

Psychiatry · Flushing, NYNPI 1235176066

Payments from drug & device makers

$2,046in general payments, 2019–2025

Across 88 payments — averaging $23.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$729
  • Teva Pharmaceuticals USA, Inc.$324
  • E.r. Squibb & Sons, L.L.C.$322
  • Neurocrine Biosciences, Inc.$262
  • Vanda Pharmaceuticals Inc.$144
  • Lundbeck LLC$102
  • plus $163 from 5 others

What the payments were for

  • Food & beverage$1,99898%
  • Education$492%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,046 in reported general payments places this provider in the 80th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York

Medicare billing

Part B allowed, 2024
$92,465
Medicare patients
99
Services billed
917

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine11$84,204
RexultiBrexpiprazole29$38,704
Risperdal ConstaRisperidone Microspheres17$32,552
TrintellixVortioxetine Hydrobromide45$31,109
Abilify MaintenaAripiprazole11$25,907
AmbienZolpidem Tartrate13$7,738
Aripiprazole119$2,779
Olanzapine114$2,624
Clonazepam254$2,125
Divalproex Sodium ErDivalproex Sodium52$1,887
Duloxetine Hcl107$1,819
Clozapine62$1,725
Asenapine Maleate12$1,638
Quetiapine Fumarate138$1,622
Venlafaxine Hcl ErVenlafaxine Hcl177$1,498

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$324$84,20411 claims
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$729$64,61240 claims
Johnson & JohnsonRisperdal Consta$48$32,55217 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,713 psychiatry providers in New York.

Other psychiatry in Flushing

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →